(Q79805141)

English

Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: A prospective randomized study in squamous cell head and neck cancer

scientific article published on 01 August 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804929%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: A prospective randomized study in squamous cell head and neck cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804929%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

head and neck cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

head and neck carcinoma

1 reference

based on heuristic

inferred from title

Berend J Slotman

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804929%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Hans Langendijk

8

object named as

Johannes A Langendijk

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804929%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

4

object named as

C Rene Leemans

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804929%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Anke Petra Jellema

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804929%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Martin J Muller

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804929%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Ludi E Smeele

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804929%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Klaas Hoekman

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804929%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Neil K Aaronson

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804929%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804929%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804929%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

107

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804929%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804929%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

544-553

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804929%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Scintigraphic assessment of early and late parotid gland function after radiotherapy for head-and-neck cancer: a prospective study of dose-volume response relationships

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

The function of the parotid gland following radiation therapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Parotid gland function during and following radiotherapy of malignancies in the head and neck. A consecutive study of salivary flow and patient discomfort

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Some factors influencing salivary function when treating with radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological Factors Affecting the Radioprotective Efficiency of S-2-[3-Aminopropylamino] Ethylphosphorothioic Acid (WR-2721). LD 50(30) Doses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Radioprotection of tumor and normal tissues by thiophosphate compounds

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of the Effective Radioprotective Dose of WR-2721 in Humans through an Interspecies Tissue Distribution Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of WR-1065 in mouse tissue following treatment with WR-2721

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Has the outlook improved for amifostine as a clinical radioprotector?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22020

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804929%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16804929%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79805141&oldid=1683156545"